GFER Represents a Target for Dual Disruption of Redox Homeostasis and Reactivation of the Immune Response in Pancreatic Adenocarcinoma
Year: 2025
Type: article
Language: en
Topic: interferon and immune responses
Authors and affiliations:
raw_author_name: Ziheng Chen
raw_affiliation_strings: 1Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas
The University of Texas MD Anderson Cancer Center, Houston, TX, United States
raw_author_name: I-Lin Ho
raw_affiliation_strings: 1Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas
The University of Texas MD Anderson Cancer Center, Houston, United States
raw_author_name: Jintan Liu
raw_affiliation_strings: 1Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas
Merck Research Laboratories, boston, ma, United States
raw_author_name: Melinda Soeung
raw_affiliation_strings: 1Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas
Dana-Farber Cancer Institute, United States
raw_author_name: Er-Yen Yen
raw_affiliation_strings: 1Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas
The University of Texas MD Anderson Cancer Center, Houston, TX, United States
raw_author_name: Sara Sainani
raw_affiliation_strings: 1Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas
2MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, Houston, Texas
The University of Texas MD Anderson Cancer Center, Houston, TX, United States
raw_author_name: Charles A. Dyke
raw_affiliation_strings: 1Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas
The University of Texas MD Anderson Cancer Center, Houston, TX, United States
raw_author_name: Rutvi Shah
raw_affiliation_strings: 1Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas
2MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, Houston, Texas
The University of Texas MD Anderson Cancer Center, Houston, TX, United States
raw_author_name: Hyuk Jean Kwon
raw_affiliation_strings: 1Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas
2MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, Houston, Texas
The University of Texas MD Anderson Cancer Center, Houston, TX, United States
raw_author_name: Guangchun Han
raw_affiliation_strings: 1Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas
The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
raw_author_name: Xinmiao Yan
raw_affiliation_strings: 1Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas
The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
raw_author_name: Shaojun Zhang
raw_affiliation_strings: 1Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas
The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
raw_author_name: Sanjana Srinivasan
raw_affiliation_strings: 1Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas
3Translational Research to Advance Therapeutics and Innovation in Oncology (TRACTION), Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, Texas
The University of Texas MD Anderson Cancer Center, United States
raw_author_name: Johnathon L. Rose
raw_affiliation_strings: 1Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas
3Translational Research to Advance Therapeutics and Innovation in Oncology (TRACTION), Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, Texas
The University of Texas MD Anderson Cancer Center, Houston, TX, United States
raw_author_name: Francesca Citron
raw_affiliation_strings: 1Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas
The University of Texas MD Anderson Cancer Center, Houston, TX, United States
raw_author_name: Shan Jiang
raw_affiliation_strings: 3Translational Research to Advance Therapeutics and Innovation in Oncology (TRACTION), Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, Texas
The University of Texas MD Anderson Cancer Center, Houston, United States
raw_author_name: Qing Chang
raw_affiliation_strings: 3Translational Research to Advance Therapeutics and Innovation in Oncology (TRACTION), Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, Texas
The University of Texas MD Anderson Cancer Center, Houston, United States
raw_author_name: Ningping Feng
raw_affiliation_strings: 3Translational Research to Advance Therapeutics and Innovation in Oncology (TRACTION), Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, Texas
The University of Texas MD Anderson Cancer Center, Houston, TX, United States
raw_author_name: Giannicola Genovese
raw_affiliation_strings: 1Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas
3Translational Research to Advance Therapeutics and Innovation in Oncology (TRACTION), Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, Texas
4Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas
5David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, Texas
The University of Texas MD Anderson Cancer Center, Houston, TX, United States
raw_author_name: Sisi Gao
raw_affiliation_strings: 1Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas
3Translational Research to Advance Therapeutics and Innovation in Oncology (TRACTION), Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, Texas
The University of Texas MD Anderson Cancer Center, Houston, United States
raw_author_name: Wantong Yao
raw_affiliation_strings: 6Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas
The University of Texas MD Anderson Cancer Center, Houston, United States
raw_author_name: Linghua Wang
raw_affiliation_strings: 1Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas
7UTHealth Houston Graduate School of Biomedical Sciences (GSBS), The University of Texas MD Anderson Cancer Center, Houston, Texas
The University of Texas MD Anderson Cancer Center, Houston, Texas, United States
raw_author_name: Huamin Wang
raw_affiliation_strings: 8Department of Pathology, Division of Pathology/Lab Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas
The University of Texas MD Anderson Cancer Center, Houston, TX, United States
raw_author_name: Haoqiang Ying
raw_affiliation_strings: 9Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, University of Texas, Houston, Texas
The University of Texas MD Anderson Cancer Center, Houston, United States
raw_author_name: Andrea Viale
raw_affiliation_strings: 1Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas
The University of Texas MD Anderson Cancer Center, Houston, United States
raw_author_name: Giulio F. Draetta
raw_affiliation_strings: 1Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas
The University of Texas MD Anderson Cancer Center, Houston, TX, United States